This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Clozapine: Difference between revisions
>David Hedlund m sort |
>David Hedlund line break |
||
| Line 5: | Line 5: | ||
{{SubstanceBox/Clozapine}} | {{SubstanceBox/Clozapine}} | ||
[[File:FazaClo and Clozaril 100 mg each side by side.png|400px|thumbnail|right|FazaClo and Clozaril 100 mg tablets.]] | [[File:FazaClo and Clozaril 100 mg each side by side.png|400px|thumbnail|right|FazaClo and Clozaril 100 mg tablets.]] | ||
'''Clozapine''', sold '''Clozaril''' and '''FazaClo''', is an [[antipsychotic|atypical antipsychotic]] substance of the tricyclic dibenzodiazepine chemical class that produces antipsychotic, hypnotic, and dulling effects when administered. It is used for treatment-resistant schizophrenia and is considered to be a "drug of last resort," reserved for when all other agents have failed.<ref> Novartis Corporation, Prescribing Guide For Clozapine (https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019758s062lbl.pdf)</ref> It is also used for schizoaffective disorder, a similar condition. FazaClo is an orally disintegrating tablet. <ref>Jazz Pharmaceuticals (2017) FazaClo Highlights of Prescribing Information</ref> | '''Clozapine''', sold '''Clozaril''' and '''FazaClo''', is an [[antipsychotic|atypical antipsychotic]] substance of the tricyclic dibenzodiazepine chemical class that produces antipsychotic, hypnotic, and dulling effects when administered. It is used for treatment-resistant schizophrenia and is considered to be a "drug of last resort," reserved for when all other agents have failed.<ref> Novartis Corporation, Prescribing Guide For Clozapine (https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019758s062lbl.pdf)</ref> It is also used for schizoaffective disorder, a similar condition. FazaClo is an orally disintegrating tablet. <ref>Jazz Pharmaceuticals (2017) FazaClo Highlights of Prescribing Information</ref> | ||
Clozapine may also be used to help reduce the risk of suicidal tendencies in people with schizophrenia or other disorders that can be similar, such as acute delirium, bipolar disorder, and extreme cases of anxiety.{{citation needed}} However, it is only approved for use (on-label) in treatment-resistant schizophrenia. Clozapine was first synthesized in 1958 by Wander AG, a Swiss pharmaceutical company, based on the structure of the tricyclic antidepressant imipramine. | Clozapine may also be used to help reduce the risk of suicidal tendencies in people with schizophrenia or other disorders that can be similar, such as acute delirium, bipolar disorder, and extreme cases of anxiety.{{citation needed}} However, it is only approved for use (on-label) in treatment-resistant schizophrenia. Clozapine was first synthesized in 1958 by Wander AG, a Swiss pharmaceutical company, based on the structure of the tricyclic antidepressant imipramine. | ||
==Chemistry== | ==Chemistry== | ||
{{chemistry}} | {{chemistry}} | ||
| Line 62: | Line 64: | ||
}} | }} | ||
}} | }} | ||
===Experience reports=== | ===Experience reports=== | ||
| Line 96: | Line 96: | ||
https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0009695/?report=details#side_effects | https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0009695/?report=details#side_effects | ||
https://www.ncbi.nlm.nih.gov/mesh/68003024 | https://www.ncbi.nlm.nih.gov/mesh/68003024 | ||
[[Category:Psychoactive substance]][[Category:Articles in talk page]][[Category:Proofread]][[Category:Approval]] | [[Category:Psychoactive substance]][[Category:Articles in talk page]][[Category:Proofread]][[Category:Approval]] | ||